Clinical Biochemistry Practice Questions

Q: Why is Troponin C not used for myocardial infarction diagnosis?

Troponin C is present in both cardiac and smooth muscle.. **Explanation:** The diagnosis of Myocardial Infarction (MI) relies on the detection of biomarkers that are highly specific to cardiac tissue. The Troponin complex consists of three subunits: **Troponin T (Trop-T)**, **Troponin I (Trop-I)**, and **Troponin C (Trop-C)**. The correct answer is **Option B**. Troponin C is not used clinically because it lacks tissue specificity. While Troponin I and T have unique cardiac isoforms (cTnI and cTnT) that differ from skeletal muscle isoforms, **Troponin C is identical in both cardiac and slow-twitch skeletal muscle**. Therefore, an elevation in Troponin C could indicate either cardiac injury or skeletal muscle damage, making it an unreliable diagnostic tool for MI. **Analysis of Incorrect Options:** * **Option A:** While Troponin C does bind to calcium (initiating contraction), this is its physiological function and not the reason it is excluded as a biomarker. * **Option C:** This is partially true but less precise than the biochemical reality that it is shared specifically with slow-twitch skeletal fibers. However, in the context of standard NEET-PG patterns, the lack of cardiac-specific isoforms is the primary disqualifier. * **Option D:** Troponin C does not necessarily elevate "late"; it is simply not measured because it cannot differentiate the source of muscle injury. **NEET-PG High-Yield Pearls:** * **Gold Standard:** Cardiac Troponins (cTnI and cTnT) are the preferred markers for MI due to high sensitivity and specificity. * **Timeline:** Troponins rise within **3–6 hours**, peak at **12–24 hours**, and remain elevated for **7–10 days** (cTnI) or up to **14 days** (cTnT). * **Re-infarction:** **CK-MB** is the marker of choice for diagnosing a second MI occurring shortly after the first, as it returns to baseline within 48–72 hours.

Q: Which of the following is the biochemical marker of choice for cholestatic jaundice of pregnancy?

Bile acids. **Explanation:** **Intrahepatic Cholestasis of Pregnancy (ICP)** is a reversible form of cholestasis occurring typically in the third trimester, characterized by intense pruritus (especially of palms and soles) without a rash. **Why Bile Acids are the Correct Answer:** The biochemical hallmark and the most sensitive marker for diagnosing and monitoring ICP is the elevation of **Total Serum Bile Acids (TSBA)**. In ICP, there is a defect in the excretion of bile acids into the bile canaliculi, leading to their accumulation in the blood. A level >10 µmol/L is diagnostic, and levels >40 µmol/L are associated with increased fetal risk (preterm birth, meconium staining, and stillbirth). **Why Other Options are Incorrect:** * **Serum Bilirubin:** While it may be elevated in some cases (clinical jaundice), it is an insensitive marker. Most patients with ICP remain non-icteric. * **Bile Salts:** While often used interchangeably in casual conversation, "Bile Acids" is the precise biochemical term used in diagnostic assays. Bile salts are the conjugated form found in the intestine. * **Alkaline Phosphatase (ALP):** ALP levels naturally increase during pregnancy (3-4 times) due to the production of the placental isoenzyme. Therefore, it lacks the specificity required to diagnose cholestasis in a pregnant patient. **Clinical Pearls for NEET-PG:** * **Primary Symptom:** Pruritus (worse at night) without a primary skin rash. * **Treatment of Choice:** **Ursodeoxycholic acid (UDCA)**, which helps lower bile acid levels and relieves itching. * **Fetal Risk:** The main concern is sudden intrauterine fetal death (IUFD) due to bile acid toxicity to the fetal myocardium. * **Resolution:** Symptoms and biochemical markers typically resolve rapidly after delivery.

Q: Microalbuminuria is defined as protein levels of:

30-300 mg/d. **Explanation:** Microalbuminuria refers to the excretion of albumin in the urine at a rate higher than normal but below the detection limit of a standard dipstick test. It is a critical clinical marker for early-stage diabetic nephropathy and cardiovascular risk. **1. Why Option A is Correct:** The standard clinical definition of microalbuminuria is the excretion of **30–300 mg of albumin over a 24-hour period**. In a healthy individual, the glomerular filtration barrier prevents most albumin from entering the filtrate; thus, normal excretion is <30 mg/day. When the barrier begins to fail (often due to hyperglycemia-induced basement membrane damage), levels rise into the 30–300 mg/day range. **2. Why Other Options are Incorrect:** * **Options B and C (100–200 mg/d):** These ranges fall *within* the spectrum of microalbuminuria but do not define its lower or upper limits. They are subsets, not the diagnostic criteria. * **Option D (301–600 mg/d):** Excretion **>300 mg/day** is classified as **Macroalbuminuria** (or overt proteinuria). At this stage, protein becomes detectable on a routine urine dipstick. **Clinical Pearls for NEET-PG:** * **ACR (Albumin-to-Creatinine Ratio):** Since 24-hour collection is cumbersome, a spot urine ACR is preferred. Microalbuminuria is defined as an ACR of **30–300 mg/g**. * **Reversibility:** This stage is clinically significant because it is the last point where renal damage may be reversible with strict glycemic control and ACE inhibitors/ARBs. * **Screening:** In Type 2 Diabetes, screen at the time of diagnosis. In Type 1 Diabetes, screen 5 years after diagnosis.

Q: Which of the following diseases has elevated uric acid levels as a diagnostic value?

Renal diseases. **Explanation:** **Why Renal Diseases is Correct:** Uric acid is the end product of purine metabolism in humans. Under normal physiological conditions, approximately **two-thirds of uric acid is excreted by the kidneys**, while the remaining one-third is eliminated via the gastrointestinal tract. In renal diseases—specifically chronic kidney disease (CKD) or acute kidney injury (AKI)—the **Glomerular Filtration Rate (GFR)** decreases. This impairment leads to reduced clearance and subsequent retention of uric acid in the blood, resulting in **hyperuricemia**. Therefore, serum uric acid levels serve as a crucial biochemical marker for monitoring renal function and progression. **Why Other Options are Incorrect:** * **Liver diseases:** The liver is the primary site of uric acid production (via the enzyme xanthine oxidase). In severe liver damage, uric acid levels typically **decrease** rather than increase due to impaired synthesis. * **Heart diseases:** While hyperuricemia is an independent risk factor for cardiovascular disease, it is not used as a primary diagnostic value for heart disease itself (where troponins or BNP are preferred). * **TMJ (Temporomandibular Joint) diseases:** These are generally structural or muscular disorders. While gout can rarely affect the TMJ, it is not a standard diagnostic marker for TMJ pathology. **High-Yield Clinical Pearls for NEET-PG:** * **Normal Serum Uric Acid:** 3–7 mg/dL. * **Lesch-Nyhan Syndrome:** An X-linked recessive deficiency of **HGPRT**, leading to severe hyperuricemia, self-mutilation, and gout. * **Tumor Lysis Syndrome:** A common cause of secondary hyperuricemia due to rapid breakdown of nucleic acids following chemotherapy. * **Drug-induced Hyperuricemia:** Remember the mnemonic **"CANT"** (Cyclosporine, Alcohol, Nicotinic acid, Thiazides/Loop diuretics).

Q: Which test best assesses the absorptive function of the intestinal mucosa?

d-Xylose test. **Explanation:** The **d-Xylose test** is the gold standard for assessing the **integrity of the intestinal mucosal surface** and its absorptive capacity. **1. Why d-Xylose is the correct answer:** D-xylose is a pentose sugar that is absorbed via passive diffusion in the proximal small intestine. Unlike other sugars, it does not require pancreatic enzymes for digestion. Once absorbed, it is not metabolized by the liver and is excreted unchanged in the urine. Therefore, low levels of d-xylose in the blood or urine after oral administration directly indicate **mucosal damage** (e.g., Celiac disease, Tropical sprue) rather than pancreatic insufficiency. **2. Why other options are incorrect:** * **NBT-PABA test:** This is a test for **exocrine pancreatic function**. It relies on the pancreatic enzyme chymotrypsin to cleave PABA from a peptide; it does not directly measure mucosal absorption. * **Stool fat estimation:** While this detects steatorrhea (malabsorption), it is **non-specific**. It cannot differentiate between maldigestion (pancreatic failure) and malabsorption (mucosal disease). * **Urobilin levels:** These are used to evaluate **hemolysis or hepatobiliary diseases** (jaundice) and have no role in assessing intestinal absorption. **High-Yield Clinical Pearls for NEET-PG:** * **Differential Diagnosis:** The d-Xylose test is specifically used to differentiate **Malabsorption** (Mucosal disease = Low xylose) from **Maldigestion** (Pancreatic disease = Normal xylose). * **False Positives:** Low urinary d-xylose can occur in patients with **renal dysfunction**, ascites, or Small Intestinal Bacterial Overgrowth (SIBO), even if the mucosa is healthy. * **Normal Values:** Typically, >4g of a 25g dose should be excreted in the urine over 5 hours.

Q: The Mucin clot test is done to detect:

Hyaluronate in synovial fluid. **Explanation:** The **Mucin Clot Test** (also known as the Rope’s test) is a qualitative biochemical analysis used to estimate the amount and quality of **hyaluronate (hyaluronic acid)** in synovial fluid. 1. **Why Option C is Correct:** Synovial fluid is rich in hyaluronic acid, a high-molecular-weight glycosaminoglycan that provides viscosity to the joints. When **glacial acetic acid (2–5%)** is added to normal synovial fluid, the hyaluronic acid reacts with the proteins in the fluid to form a firm, tight "mucin" clot. In inflammatory conditions like Rheumatoid Arthritis or Septic Arthritis, the hyaluronate is degraded or diluted, resulting in a "poor" or "friable" clot that fragments easily. 2. **Why Other Options are Incorrect:** * **Option A:** Mucin in stool is typically assessed via visual inspection or specific staining (like Mucicarmine) in histopathology, not the Mucin Clot Test. * **Option B & D:** Protein in CSF or pleural fluid is measured using quantitative methods like the **Pandy’s test** (for globulins in CSF) or the **Biuret method**. These fluids do not contain the high concentrations of hyaluronate required to form a "mucin clot." **High-Yield Clinical Pearls for NEET-PG:** * **Normal Synovial Fluid:** Forms a tight, ropy clot (Good). * **Inflammatory/Infectious Arthritis:** Forms a friable, shredded clot (Poor). * **Note:** Despite the name, the test does **not** detect actual "mucin" (the glycoprotein found in mucus); it detects the complex formed by hyaluronic acid. * **Viscosity Test:** Another bedside test for hyaluronate is the "String Sign"—normal synovial fluid should form a string 3–5 cm long when dropped from a syringe.

Q: A 45-year-old male presents with a blood sample that yields a purple-brown color in Ehrlich's solution. What is the substance responsible for this color change?

Urobilinogen. ### Explanation **Correct Answer: A. Urobilinogen** The **Ehrlich’s Aldehyde Test** is a classic biochemical reaction used to detect urobilinogen in urine or blood. The reagent (Ehrlich’s reagent) consists of **p-dimethylaminobenzaldehyde** in concentrated hydrochloric acid. When this reagent reacts with urobilinogen, it forms a characteristic **cherry-red to purple-brown condensation product**. This is a high-yield clinical marker for hemolytic anemias and hepatocellular jaundice, where urobilinogen levels are significantly elevated. **Why the other options are incorrect:** * **B & C (Bilirubin):** Bilirubin (both conjugated and unconjugated) does not react with Ehrlich’s reagent. Conjugated bilirubin is typically detected using the **Fouchet’s test** (producing a green color) or the **Van den Bergh reaction** (producing a purple azobilirubin compound). * **D (Hemosiderin):** This is an iron-storage complex. It is detected using the **Prussian Blue (Perls') reaction**, which yields a deep blue color, not a purple-brown reaction with aldehyde reagents. **NEET-PG High-Yield Pearls:** * **Ehrlich’s Test:** Positive in hemolytic jaundice (increased production) and early hepatitis; **Negative/Absent** in obstructive jaundice (bile cannot reach the gut for conversion). * **Watson-Schwartz Test:** A modification of Ehrlich’s test used to differentiate between urobilinogen and **porphobilinogen (PBG)**. PBG is insoluble in chloroform, whereas urobilinogen is soluble. * **False Positives:** Certain drugs like sulfonamides and PAS (Para-aminosalicylic acid) can cause a false-positive Ehrlich’s reaction.

Q: Which of the following statements is true regarding glycosylated hemoglobin?

Contains hemoglobin with a sugar moiety.. **Explanation:** **1. Why the correct answer is right:** Glycosylated hemoglobin (HbA1c) is formed by a **non-enzymatic, irreversible attachment** of glucose to the N-terminal valine residue of the beta-globin chain (glycation). Chemically, it consists of a hemoglobin molecule covalently bonded to a **sugar moiety**. This process is dependent on the ambient blood glucose concentration, making it a reliable marker for glycemic control. **2. Why the incorrect options are wrong:** * **Option A:** In patients with **Sickle Cell Anemia**, the lifespan of red blood cells (RBCs) is significantly reduced due to hemolysis. Since there is less time for glucose to bind to hemoglobin, HbA1c levels are **falsely decreased**, not increased. * **Option B:** While HbA1c can be affected by erythropoietin therapy or uremia in renal disease, it remains a standard tool. However, the statement is generally considered incorrect because HbA1c reflects the average glucose over 2-3 months; the "poor indicator" label is more accurately applied to conditions with high RBC turnover. * **Option D:** HbA1c does not have a half-life of 45 days. Instead, it reflects the **average lifespan of an RBC**, which is approximately **120 days**. It provides a retrospective index of blood glucose control over the preceding 8–12 weeks. **Clinical Pearls for NEET-PG:** * **Gold Standard:** HbA1c is the gold standard for monitoring long-term glycemic control. * **Target:** For most diabetic patients, the target HbA1c is **< 7%**. * **Fructosamine Test:** If HbA1c is unreliable (e.g., hemolytic anemia, pregnancy), the Fructosamine test (measuring glycated albumin) is used, reflecting control over the past **2–3 weeks**. * **False Lows:** Seen in Hemolytic anemia, acute blood loss, and Vitamin C/E supplementation. * **False Highs:** Seen in Iron deficiency anemia (due to increased RBC lifespan) and Splenectomy.

Question 1

Why is Troponin C not used for myocardial infarction diagnosis?

Accepted Answer

Troponin C is present in both cardiac and smooth muscle.

Answer

Troponin C binds to calcium.

Answer

Troponin C is present in both cardiac and skeletal muscle.

Answer

It elevates late after the onset of myocardial infarction.

Question 2

Which of the following is the biochemical marker of choice for cholestatic jaundice of pregnancy?

Accepted Answer

Bile acids

Answer

Serum Bilirubin

Answer

Bile salts

Answer

Alkaline phosphatase levels

Question 3

Microalbuminuria is defined as protein levels of:

Accepted Answer

30-300 mg/d

Answer

151-200 mg/d

Answer

100-150 mg/d

Answer

301-600 mg/d

Question 4

Which of the following diseases has elevated uric acid levels as a diagnostic value?

Accepted Answer

Renal diseases

Answer

Liver diseases

Answer

Heart diseases

Answer

TMJ diseases

Question 5

Which test best assesses the absorptive function of the intestinal mucosa?

Accepted Answer

d-Xylose test

Answer

NET-PABA test

Answer

Stool fat estimation

Answer

Urobilin levels

Question 6

A pregnant female presented with a family history of diabetes. Her glucose tolerance test (GTT) is positive. All of the following are TRUE about GTT, EXCEPT?

Accepted Answer

The patient is instructed to drink glucose within 10 minutes

Answer

It is useful in reactive hypoglycemia

Answer

Fasting of 8-12 hours is required

Answer

The most important sample is at 2 hours

Question 7

The Mucin clot test is done to detect:

Accepted Answer

Hyaluronate in synovial fluid

Answer

Mucin in stool

Answer

Protein in cerebrospinal fluid (CSF)

Answer

Protein in pleural fluid

Question 8

A 45-year-old male presents with a blood sample that yields a purple-brown color in Ehrlich's solution. What is the substance responsible for this color change?

Accepted Answer

Urobilinogen

Answer

Conjugated bilirubin

Answer

Unconjugated bilirubin

Answer

Hemosiderin

Question 9

In acute liver injury, what is the characteristic AST/ALT ratio?

Accepted Answer

An AST/ALT ratio < 1 occurs in most hepatocellular conditions.

Answer

An AST/ALT ratio > 2:1 is suggestive of alcoholic liver disease.

Answer

The synthesis of AST is inhibited by ethanol.

Answer

In alcoholic liver disease, the AST/ALT ratio is typically < 1.

Question 10

Which of the following statements is true regarding glycosylated hemoglobin?

Accepted Answer

Contains hemoglobin with a sugar moiety.

Answer

Increased in diabetic patients with sickle cell anemia.

Answer

It is a poor indicator of long-term diabetic status in patients with renal disease.

Answer

Has a half-life of 45 days in adults.

Clinical Biochemistry — MCQs

Clinical Biochemistry — MCQs

On this page

Practice by Chapter

Want unlimited practice?